A novel neuromuscular blocker binding agent - Sugammadex
— · The Internet Journal of Anesthesiology · 2008
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Internet Journal of Anesthesiology · Internet Scientific Publications · article · 2008
Abstract
A novel approach to reversing neuromuscular blockade is sugammadex (Org 25969). It acts by rapidly encapsulating steroidal NMBDs to form a stable complex at a 1:1 ratio and thus decreasing the free concentration of the drug from the plasma. The encapsulated complex of sugammadex and NMBD are freely filtered by the glomerulus into the urine. The dose-dependency can be readily explained by the need to bind more rocuronium in plasma as blockade becomes deeper. Sugammadex could solve the problems of residual paralysis and failed intuba¬tion.
In view of the potential of sugammadex to reverse even a profound NMB, and its favorable safety profile, this agent may fulfill the criteria of an ideal reversal agent for rocuronium. Continued safety and efficacy for this promising agent will be confirmed in future clinical studies.
Open the resolved locator · 10.5580/ca
Metadata licence: OpenAlex metadata (CC0)